Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier

被引:206
作者
Chang, Jiang [1 ,2 ,3 ]
Jallouli, Youssef [3 ]
Kroubi, Maya [1 ]
Yuan, Xu-bo [2 ]
Feng, Wei [2 ]
Kang, Chun-sheng [4 ]
Pu, Pei-yu [4 ]
Betbeder, Didier [1 ,3 ]
机构
[1] Univ Lille 2, EA 2689, Physiol Lab, IMPRT,Fac Med, F-59045 Lille, France
[2] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China
[3] Univ Artois, EA 2648, Lab Bood Brain Barrier, IMPRT,Fac Sci Jean Perrin, F-62307 Lens, France
[4] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Lab Neurooncol,Tianjin Neurol Inst, Tianjin 300052, Peoples R China
关键词
PLGA; Nanoparticles; blood-brain barrier; Transferrin; Caveolae; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; CELLS IN-VITRO; ENDOTHELIAL-CELLS; DRUG-DELIVERY; CYANOACRYLATE) NANOPARTICLES; MEDIATED TRANSPORT; TRANSCYTOSIS; RECEPTOR; DISEASE;
D O I
10.1016/j.ijpharm.2009.04.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Many studies showed that transferrin increases brain delivery of nanoparticles (NPs) in vivo, however the mechanisms implied in their brain uptake are not yet clearly elucidated. In this study we evaluated the endocytosis of PLGA NPs coated with transferrin on an in vitro model of the blood-brain barrier (BBB) made of a co-culture of brain endothelial cells and astrocytes. PLGA NPs were prepared using Dil as a fluorescent marker and coated with Tween (R) 20, BSA and transferrin (Tf). Blank and BSA-NPs served as controls. The cellular toxicity on BBB of the different samples was evaluated following tight junction aperture and due to high toxicity NPs prepared with Tween (R) 20 were discarded. The size of the NPs prepared by the solvent diffusion method, varied from 63 to 90 nm depending on Dil incorporation and surface coating. Proteins adsorption on the surface of the NPs was found to be stable for at least 12 days at 37 degrees C. Contrary to Blank or BSA-NPs, Tf-NPs were found to be highly adsorbed by the cells and endocytosed using an energy-dependent process. Studies in presence of inhibitors suggest that Tf-NPs interact with the cells in a specific manner and enter the cells via the caveolae pathway. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 46 条
[1]   A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization [J].
Abdelwahed, W ;
Degobert, G ;
Fessi, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 309 (1-2) :178-188
[2]   Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 [J].
Aktas, Y ;
Yemisci, M ;
Andrieux, K ;
Gürsoy, RN ;
Alonso, MJ ;
Fernandez-Megia, E ;
Novoa-Carballal, R ;
Quiñoá, E ;
Riguera, R ;
Sargon, MF ;
Çelik, HH ;
Demir, AS ;
Hincal, AA ;
Dalkara, T ;
Çapan, Y ;
Couvreur, P .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1503-1511
[3]   Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J].
Alyautdin, RN ;
Petrov, VE ;
Langer, K ;
Berthold, A ;
Kharkevich, DA ;
Kreuter, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (03) :325-328
[4]   Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats [J].
Ambruosi, A ;
Khalansky, AS ;
Yamamoto, H ;
Gelperina, SE ;
Begley, DJ ;
Kreuter, J .
JOURNAL OF DRUG TARGETING, 2006, 14 (02) :97-105
[5]   Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models [J].
Ataman-Onal, Yasemin ;
Munier, Severine ;
Ganee, Arnaud ;
Terrat, Celine ;
Durand, Pierre-Yves ;
Battail, Nicole ;
Martinon, Frederic ;
Le Grand, Roger ;
Charles, Marie-Helene ;
Delair, Thierry ;
Verrier, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 112 (02) :175-185
[6]   Uptake and transport of high-density lipoprotein (HDL) and HDL-associated α-tocopherol by an in vitro blood-brain barrier model [J].
Balazs, Z ;
Panzenboeck, U ;
Hammer, A ;
Sovic, A ;
Quehenberger, O ;
Malle, E ;
Sattler, W .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) :939-950
[7]   Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method [J].
Barichello, JM ;
Morishita, M ;
Takayama, K ;
Nagai, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (04) :471-476
[8]   Delivery of peptides and proteins through the blood-brain barrier (Reprinted from Advanced Drug Delivery Reviews, vol 10, pg 205-245, 1993) [J].
Bickel, U ;
Yoshikawa, T ;
Pardridge, WM .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :247-279
[9]   Solid lipid nanoparticles for targeted brain drug delivery [J].
Blasi, Paolo ;
Glovagnoli, Stefano ;
Schoubben, Aurelie ;
Ricci, Maurizio ;
Rossi, Carlo .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :454-477
[10]   Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS [J].
Boado, RJ ;
Tsukamoto, H ;
Pardridge, WM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) :1308-1315